Neurology Update 2013
Neurology Update 2013
Saturday • September 7, 2013 • Overland Park Marriott, Overland Park, Kan.
Register

Contact

  • Marla Sutton, MS
    Senior Program Manager
    KU Medical Center
    Continuing Education
    3901 Rainbow Blvd.
    Kansas City, KS 66160
  • 913-588-4487
  • msutton@kumc.edu


 
Join Mailing List Now


Bookmark and Share

Sponsored by the University of Kansas Medical Center Department of Neurology and Department of Continuing Education and Professional Development

Course Director

Richard Barohn, MD, Chairman and Gertrude and Dewey Ziegler Professor of Neurology, University of Kansas Medical Center, Kansas City, Kan.

Overview

Neurology Update is presented by academic-affiliated physicians and provides an up-to-date review of clinical issues related to neuromuscular diseases, stroke, epilepsy, multiple sclerosis, dementia, movement disorders and sleep disorders.

Target Audience

This program is designed for neurologists.

Objectives

After this program, participants should be able to:

  • Recognize the neuromuscular diseases that can potentially be treated with IVIG and understand the dosages and potential side effects.
  • Discuss the results of recent randomized controlled trials regarding the acute treatment of ischemic stroke.
  • Discuss the diagnosis and treatment options for multiple sclerosis.
  • Discuss complex clinical presentations of chronic migraine, co-morbidities and pathophysiology. Review the evidence-based management of migraine.
  • Discuss the phenomenology, pathophysiology and treatment of common hyperkinetic movement disorders.
  • Identify non-motor symptoms of Parkinson’s disease and understand the various treatment options.
  • Review common and uncommon entrapment neuropathies and discuss management of neuropathic pain.
  • Understand the diagnostic criteria and evaluation for medically refractory epilepsy. Discuss the efficacy of resective epilepsy surgery for temporal lobe epilepsy.
  • Discuss Alzheimer’s disease treatment options and advances in the clinical use of diagnostic biomarkers.

Acknowledgments

Financial contributions and supporters of this program will be acknowledged in print at the symposium.



CM142003


The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.